[1]
J. Li, “In vivo and in vitro action mechanism of treatment of glucocorticoid-induced osteoporosis by regulation of osteoprotegerin/receptor activator of nuclear factor-κB pathways by denshensu: Treatment of glucocorticoid-induced osteoporosis by denshensu”, Cell Mol Biol (Noisy-le-grand), vol. 69, no. 10, pp. 67–74, Oct. 2023.